Inspiration

Every year, thousands of elderly patients are re-hospitalized because of a simple naming mistake. A hospital prescribes generic Atorvastatin, but at home they still have brand Lipitor. To them, it's two different pills. To their body, it's a double dose. I wanted to stop this preventable error at the critical post-hospital transition.

What it does

RxBridge prevents post-hospital double-dosing. It scans 1) the hospital discharge order and 2) the home medicine cabinet. It grounds every drug name via NLM RxNorm API to its active ingredient (RXCUI), detects brand-generic duplication, flags toxicity risk, and instantly generates a Pharmacist Consultation Memo the family can show before the next dose.

How we built it

I built it entirely with Anti-Gravity Agent anti Devpost challenge skills

I prompted the agent to scaffold a full-stack app for the reconciliation UI, RxNorm API integration for grounding, rule-engine for duplication + dosage logic, and PDF generation for the pharmacist memo. Anti-Gravity handled code generation, API wiring, and UI states.

Challenges we ran into

I ran into coding agent limit

Accomplishments that we're proud of

I went from idea to working, testable clinical safety tool in hours using Anti-Gravity.

What we learned

Brand names hide chemistry. Most medication reconciliation tools just list drugs; they don't explain why two names are dangerous. Grounding via RxNorm and translating it into human, actionable safety language is where the real value is.

What's next for Rxbridge

  1. Camera scan of pill bottles at home
  2. Integration with FHIR discharge summaries
  3. More duplication classes: drug-drug interactions, renal dosing, duplicate therapy class
  4. Direct share to retail pharmacist

Built With

Share this project:

Updates

Submission history